Jennifer Ko

Mud Phud Mother of three. Grown up jock Geek. Lover of Immunology Pathology Family Nature Food Drinks Dancing and Laughing.

[CNN @CNN]

A snowfall in northern Ohio inspired a cancer patient's daughter to write a message to her mom in the fresh snow outside her hospital room at the Cleveland Clinic https://t.co/khczFVo067

[Jennifer Ko @JenniferKo79]

@HarkerDavid Edv

[Nature Medicine @NatureMedicine]

Fecal #microbiome transplantation or probiotic therapy extends the lifespan and improves the health status of progeroid mice, suggesting a link between the gut microbiota and aging | https://t.co/1gKNHV16QN

[NEJM @NEJM]

#VisualAbstract: Trial shows pembrolizumab adjuvant therapy effective in increasing recurrence-free survival in patients with resected stage III #melanoma.

[Nature Biomedical Engineering @natBME]

A vaccine based on induced pluripotent stem cells mimicking the expression of tumour-cell antigens induces significant antitumour immune responses in mouse models. [N&V on this @CellStemCell paper: https://t.co/Bn1mDrApE8]
https://t.co/tOGqKpHOJO

[The New York Times @nytimes]

In Opinion

Michael Hayden, the former director of the CIA, writes, "We in the intelligence world have dealt with obstinate and argumentative presidents through the years. But we have never served a president for whom ground truth really doesn’t matter."
https://t.co/ys9WIWugjG

[Jennifer Ko @JenniferKo79]

@FunchainMD discussing the mechanisms that translate into years saved for #melanoma in the new era of #Immunotherapy #CCFDerm18

[Pauline Funchain @FunchainMD]

.@JenniferKo79 on rational molecular analysis of melanoma that is clinically comprehensive and saves precious tissue #CCFDerm18

[Jennifer Ko @JenniferKo79]

@FunchainMD @aakonc @AzizNazhaMD @Cihan_Ay_MD @NicoleKuderer @PatelOncology @JackWestMD @n8pennell @subatomicdoc @pfanderson @2020science @BNerlich @WesHerche @Jackstilgoe @ltelkins @xriskology @katinamichael @dsky @dylewskia @NoetheMatt @morningporch @Wrenaissance @mandosally @westr @MeredithGould @sonyahuber @lanisia @DrHBurstein @BreastDocUK @roentgen66 @nxtstop1 @JFreemanDaily @MKnoll_MD @mtmdphd @MikkaelSekeres @CancerConnector @drdonsdizon @davidgrahammd @RielyMD @GilliganTimothy @MaverickNY @Frank_S_David @CarrawayHetty @PGrivasMDPhD @montypal @npjccf @katyktsai @DavendraSohal I’ll have to try that

[John Gross, MD @JMcMahonG]

Excited for #USCAP2018!! Come attend our platform on cutaneous sarcomas and their mimics with sr. authors @JenniferKo79 and @SteveBillingsMD at #dermpath platform on Tues 130-145 pm VCC West 202-204 @TheUSCAP #vancouver #sarcoma @CLEClinicLabs @CreightonSOM

[Jerad Gardner, MD @JMGardnerMD]

Spindle cell lipoma CAN occur in women (14% of cases), and in women they are often in extremities rather than shawl area. -@SteveBillingsMD. His @amjsurgpathol paper w @JenniferKo79: https://t.co/vgyoOaK545. #USCAP2018 #pathology #BSTpath

[Jennifer Ko @JenniferKo79]

Propranolol for Off-label Treatment of Patients With Melanoma https://t.co/fNGjqxX9K5

[JAMA Oncology @JAMAOnc]

Leisure-time physical activity was associated with lower risks of many cancer types with greatest effects for cancers of the
- Esophagus (HR, 0.58; 95% CI, 0.37-0.89)
- Liver (HR, 0.73; 95% CI, 0.55-0.98) and
- Lung (HR, 0.74; 95% CI, 0.71-0.77)
https://t.co/5pBAfLEGvi

[Sanjay Mukhopadhyay @smlungpathguy]

Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling | Modern Pathology https://t.co/27d87ZEbOZ

[JAMA Oncology @JAMAOnc]

High response rate (72%) & tolerability for trial of #cetuximab w modified FOLFOXIRI, then maint cetux or #bevacizumab for pts w/unresectable RAS & BRAF wild type metastatic #ColorectalCancer. https://t.co/j4KEF60z34 #GICSM

[Pauline Funchain @FunchainMD]

When #genomics and #immunotherapy interact, it’s not just MMR deficiency anymore - extraordinary response in SMARCA4 mutant cancers https://t.co/tIKEgsYE1F

[Pauline Funchain @FunchainMD]

One challenge in cancer prevention is missing the window of opportunity to test for cancer predisposition genes for young people diagnosed with cancer and enact prevention going forward -Patricia Ganz #SurvOnc18

[Melanoma Research @MelanomaReAlli]

MRA Applauds FDA Approval of Nivolumab to Reduce the Risk of Melanoma Returning After Surgery https://t.co/Sd4ZPvhPpQ

[JAMA Oncology @JAMAOnc]

Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors https://t.co/0Vw15XdRKi